| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.015 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |